1:2 Bonus Issue & Both FIIs and DIIs Increased Stake in Q1 FY25: This Smallcap Company Announced Record Date for Bonus Share!
The company's shares have delivered an impressive return of over 200 per cent to their shareholders in just one year.
Incorporated in 1981, Gujarat Themis Biosyn Ltd specializes in manufacturing and selling finished Active Pharmaceutical Ingredients through a fermentation process. During the Board meeting held today, Friday, July 26, 2024, several key decisions were made:
The Company has set Friday, August 9, 2024, as the "Record Date" to determine the eligibility of shareholders for the issuance of bonus Shares. The resolution for issuing Equity Bonus Shares was approved by shareholders at the 43rd AGM held on July 23, 2024. Earlier, the company announced a bonus issue of 1 (one) Bonus Share for every 2 (two) Equity Shares held by shareholders as of the Record Date.
On Friday, the company’s stock closed at Rs 483.75 on the BSE, with a current market capitalization of Rs 3,514.13 crore. The shares have delivered a multibagger return of over 200 per cent in just one year.
As per the Quarterly Results in Q1 FY25 Gujarat Themis Biosyn Ltd reported revenue of Rs 39 crore, representing a year-on-year de-growth of 21.70 per cent from Rs 50 crore same quarter last year. The company posted an operating profit of Rs 19 crore, compared to a profit of Rs 24 crore in the same quarter last year. Surprisingly, the company's operating profit margins slightly increased from 47 per cent to 48 per cent despite a fall in operating profits and revenue. The company’s net profit stood at Rs 13 crore in the Q1 FY25.
DSIJ's ‘Penny Pick’ service provides research-backed penny stock recommendations below Rs. 100. If this interests you, do download the service details here.
According to the latest update, the promoters' stake stood at 70.87 per cent while FIIs held 1.44 per cent which increased from 1.05 per cent. The DIIs stake also increased from 0.82 per cent to 1.18 per cent as per the recent update.
To read my recent articles please click here.
Investors must keep this Small-Cap multibagger stock on their radar.
Disclaimer: The article is for informational purposes only and not investment advice.